Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centered Study to Assess the Complication Rates of Oncology Patients Accessed With Peripheral Intravenous Lines Versus Implantable Ports for Chemotherapy Administration

NCT02792764 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT02792764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02792764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centered Study to Assess the Complication Rates of Oncology Patients Accessed With Peripheral Intravenous Lines Versus Implantable Ports for Chemotherapy Administration
Lead sponsor
C. R. Bard
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
March 31, 2015
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ports/peripheral ivs complication rates